Mesa Labs Cuts 6% of Workforce, Targets $5M Net Annual Savings
MLAB sits 92% above its 52-week low of $66.56.
Summary
Mesa Laboratories announced a restructuring eliminating about 40 positions, roughly 6% of its workforce, to cut annualized costs by $9.3 million. The company will reinvest $4.3 million of those savings into growth areas like Calibration Solutions and Asia, leaving a net annualized reduction of $5.0 million. The cuts concentrate in the Clinical Genomics division, where Mesa is deliberately shrinking low-margin revenue to improve profitability. Pre-tax charges are estimated at $2.6 million to $3.4 million, mostly in the second half of fiscal 2027. Management expects the savings to be fully reflected by the end of fiscal 2028 and will provide updated guidance with Q2 results on November 9, 2026.
Updates
· SEC 8-K — The 8-K states the restructuring was approved by the board on October 6, 2026, and includes exiting the Hamburg, Germany facility when its lease expires in February 2027.
At the time of this announcement, MLAB was trading at $128.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $716.7M. The 52-week trading range was $66.56 to $144.35. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.